Amy DuRoss joins CSafe Global as President of Cell and Gene Therapy, Driving Innovation and Solutions

MONROE, OH July 26, 2022 -- Innovative leadership in temperature-controlled transportation solutions for life-enhancing drug transportation CSafe Global announced today that Amy DuRoss has joined the company as President of Cell and Gene Therapy (CGT).

Amy DuRoss, President, Cell and Genetic Solutions, CSafe

In this new role, DuRoss will lead CSafe's portfolio of CGT solutions, supporting intelligence in high-value personalized therapies and vaccines Shipping to meet unprecedented global supply chain shipping complexities for CGT products.

Ms. DuRoss brings over 25 years of experience to her new role. Before joining CSafe, she was the co-founder and CEO of Vineti. Vineti is an enterprise software platform that provides digital services for the identity chain and the chain of custody requirements for CGT products. During his early career, DuRoss has held several prominent positions, including Chief Commercial Officer of Navigenics, Director of the Office of the California Institute for Regenerative Medicine (CIRM), and co-founder, co-author and co-founder of California's $3 billion Stem Cell Research Referendum Program. executive Director.

CSafe CEO Patrick Schafer said: "We are delighted that Amy is leading our CGT team. and entrepreneurial experience is the right combination to drive innovation and exceptional solutions in this extremely complex supply chain. We look forward to significant progress in this portfolio under Amy's strategic direction."

"I am honored to have the opportunity to work with the world-class team at CSafe Global to develop the most advanced technologies in personalized medicine, cell and gene therapy An exciting area of innovation delivering a new standard in high-quality, high-value supply chain transportation." DuRoss said: "CSafe Global has an outstanding global service network and proven expertise to drive supply through robust, actionable analytics. chain efficiencies, thereby accelerating the industrialization of emerging markets and providing vital hope to a growing number of patients in need."

Ms. DuRoss  holds a bachelor's degree and dual master's degrees from Stanford University, including an MBA. She serves on the boards of Biolife Solutions (BLFS), MJH, Americans for Cures, and the ARM Foundation, and is a member of the Aspen Institute Global Network.

Media Contact:

Lori Conaway

Global Marketing Communications

+1 405.633.2344